Skip to content
A New Vaccine Frontrunner episode artwork

May 28, 2020 12 min

A New Vaccine Frontrunner

from Prognosis: Misconception Hosted by Bloomberg

As competitors publicly entered the race to produce a vaccine, drug giant Merck stayed quiet about its development plans. Now, the company has revealed it’s working on two vaccines and a treatment pill -- emerging as a frontrunner in the development contest. Although the company has refused to give firm timelines for its research, it has pledged to make its vaccines and pill available globally, if they're successful. Riley Griffin talked with Merck Chief Executive Kenneth C. Frazier about the company's plans.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

A New Vaccine Frontrunner

0:00 12:50

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Prognosis: Misconception?

This episode is 12 minutes long.

When was this Prognosis: Misconception episode published?

This episode was published on May 28, 2020.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Prognosis: Misconception episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.